22 July 2024

Multiplexing (native) mass spectrometry

Native mass spectrometry (nMS) is one of the less commonly used fragment-finding methods. The approach entails mixing proteins and ligands and gently ionizing them under non-denaturing conditions to look for complexes. As with many other methods, multiple fragments can be screened in a single sample. In a new ACS Med. Chem. paper, Ray Norton and collaborators at Monash University and CSIRO report screening multiple proteins in a single sample.
 
The researchers were interested in fatty acid-binding proteins, or FABPs. As their name suggests, these transporter proteins shuttle lipophilic molecules such as fatty acids around cells. The ten human isoforms are expressed in different tissues and have different functions in metabolic signaling, but their similarity to one another has made finding selective chemical probes difficult. Enter nMS.
 
FABP isoforms 1-5 are the most heavily studied, and these were first assessed individually. They ionized well, though in some cases peaks corresponding to both the native protein and a complex with acetic acid was observed, not surprising given that the buffer contained 50 mM ammonium acetate.
 
Next, all five proteins were mixed together at 10 µM each. All the proteins could still be observed (with or without bound acetate), though some proteins did give stronger signals than others due to differences in ionization efficiency.
 
Adding small molecule WY14643, which the researchers had previously found to bind to FABPs in a fluorescence polarization (FP) assay, led to a more complex spectrum, with peaks corresponding to unbound proteins, proteins bound to WY14643, proteins bound to acetate, and proteins bound to both acetate and WY14643. When WY14643 was added at 10 µM, the selectivity profile was consistent with the FP data. Interestingly though, when ligand was added at the total concentration of all protein isoforms (50 µM), the selectivity profile changed. The researchers suggest this may be due to nonspecific binding at higher ligand concentrations, as has been seen previously for nMS.
 
To explore the generalizability of multiplexing nMS, the researchers turned to more potent (nanomolar) ligands. As with WY14643, these molecules showed good agreement with published selectivity rankings at lower ligand concentrations with some non-specific binding at higher concentrations.
 
When I first wrote about nMS back in 2010, I noted that “the stability of protein-small molecule complexes in native mass spectrometry assays does not necessarily correlate with the (more relevant) solution-phase affinity,” and this fact is investigated in the paper. Careful optimization of the experimental conditions, including ionization voltage and temperature, led to good relative selectivity rankings for a given ligand across the different FABP isoforms but differences in absolute values from those measured by ITC.
 
Another challenge is the fact that the five FABP isoforms tested have similar molecular weights; in one case a ligand complexed with FABP3 was difficult to distinguish from free FABP2. The researchers could solve this by using different protein constructs, such as a hexa-histidine-tagged version of FABP3.
 
Overall this is an interesting approach, and the paper does an excellent job describing the technical details and limitations. Along with protein-observed 19F NMR, mass spectrometry is a rare experimental technique suitable for screening mixtures of proteins in solution. Indeed, this becomes even easier when screening covalent binders, as seen in this paper from 2003, since there is no need to worry about ligand dissociation during ionization. And with the increasing interest in covalent drugs, the use of MS is only likely to increase.

No comments:

Post a Comment